Author

M. Lu

View on Semantic Scholar

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Plasma P‐tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease

This analysis of the phase 3 TRAILBLAZER‐ALZ 2 trial examined whether plasma tau protein phosphorylated at threonine 217 (p‐tau217) level can reliably monitor treatment‐related amyloid clearance (TRAC) after donanemab treatment in early symptomatic Alzheimer's disease (AD).

Emily C. Collins, M. Lu, Rose C. Beck et al. · Alzheimer's & Dementia · 0 citations